vs
Ametek（AME）与唐纳森（DCI）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是唐纳森的2.1倍（$2.0B vs $935.4M）。Ametek净利率更高（19.9% vs 12.2%，领先7.8%）。Ametek同比增速更快（13.4% vs 3.9%）。Ametek自由现金流更多（$527.3M vs $111.2M）。过去两年Ametek的营收复合增速更高（7.3% vs 3.3%）
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
唐纳森是全球知名的过滤解决方案提供商，主要生产销售适配工商业、航空航天、化工、新能源（风电）、食品饮料、医药等多领域的过滤产品，其位于明尼苏达州明尼阿波利斯的研发部门也参与多项军事应用相关的国防项目。
AME vs DCI — 直观对比
营收规模更大
AME
是对方的2.1倍
$935.4M
营收增速更快
AME
高出9.5%
3.9%
净利率更高
AME
高出7.8%
12.2%
自由现金流更多
AME
多$416.1M
$111.2M
两年增速更快
AME
近两年复合增速
3.3%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $935.4M |
| 净利润 | $398.6M | $113.9M |
| 毛利率 | 36.0% | 35.2% |
| 营业利润率 | 25.3% | 16.0% |
| 净利率 | 19.9% | 12.2% |
| 营收同比 | 13.4% | 3.9% |
| 净利润同比 | 2.9% | 15.1% |
| 每股收益（稀释后） | $1.73 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMEDCI
| Q4 25 | $2.0B | $935.4M | ||
| Q3 25 | $1.9B | $980.7M | ||
| Q2 25 | $1.8B | $940.1M | ||
| Q1 25 | $1.7B | $870.0M | ||
| Q4 24 | $1.8B | $900.1M | ||
| Q3 24 | $1.7B | $935.4M | ||
| Q2 24 | $1.7B | $927.9M | ||
| Q1 24 | $1.7B | $876.7M |
净利润AMEDCI
| Q4 25 | $398.6M | $113.9M | ||
| Q3 25 | $371.4M | $114.3M | ||
| Q2 25 | $358.4M | $57.8M | ||
| Q1 25 | $351.8M | $95.9M | ||
| Q4 24 | $387.3M | $99.0M | ||
| Q3 24 | $340.2M | $109.7M | ||
| Q2 24 | $337.7M | $113.5M | ||
| Q1 24 | $310.9M | $98.7M |
毛利率AMEDCI
| Q4 25 | 36.0% | 35.2% | ||
| Q3 25 | 36.3% | 34.5% | ||
| Q2 25 | 35.8% | 34.2% | ||
| Q1 25 | 36.1% | 35.2% | ||
| Q4 24 | 36.6% | 35.5% | ||
| Q3 24 | 36.0% | 35.8% | ||
| Q2 24 | 36.0% | 35.6% | ||
| Q1 24 | 34.1% | 35.2% |
营业利润率AMEDCI
| Q4 25 | 25.3% | 16.0% | ||
| Q3 25 | 25.8% | 15.5% | ||
| Q2 25 | 26.0% | 9.3% | ||
| Q1 25 | 26.3% | 14.4% | ||
| Q4 24 | 26.6% | 14.5% | ||
| Q3 24 | 26.1% | 15.6% | ||
| Q2 24 | 25.8% | 15.5% | ||
| Q1 24 | 24.0% | 14.8% |
净利率AMEDCI
| Q4 25 | 19.9% | 12.2% | ||
| Q3 25 | 19.6% | 11.7% | ||
| Q2 25 | 20.2% | 6.1% | ||
| Q1 25 | 20.3% | 11.0% | ||
| Q4 24 | 22.0% | 11.0% | ||
| Q3 24 | 19.9% | 11.7% | ||
| Q2 24 | 19.5% | 12.2% | ||
| Q1 24 | 17.9% | 11.3% |
每股收益（稀释后）AMEDCI
| Q4 25 | $1.73 | $0.97 | ||
| Q3 25 | $1.60 | $0.97 | ||
| Q2 25 | $1.55 | $0.48 | ||
| Q1 25 | $1.52 | $0.79 | ||
| Q4 24 | $1.67 | $0.81 | ||
| Q3 24 | $1.47 | $0.90 | ||
| Q2 24 | $1.45 | $0.92 | ||
| Q1 24 | $1.34 | $0.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.0M | $210.7M |
| 总债务越低越好 | $2.3B | $671.5M |
| 股东权益账面价值 | $10.6B | $1.5B |
| 总资产 | $16.1B | $3.0B |
| 负债/权益比越低杠杆越低 | 0.21× | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资AMEDCI
| Q4 25 | $458.0M | $210.7M | ||
| Q3 25 | $439.2M | $180.4M | ||
| Q2 25 | $619.7M | $178.5M | ||
| Q1 25 | $399.0M | $189.1M | ||
| Q4 24 | $374.0M | $221.2M | ||
| Q3 24 | $396.3M | $232.7M | ||
| Q2 24 | $396.6M | $223.7M | ||
| Q1 24 | $373.8M | $193.8M |
总债务AMEDCI
| Q4 25 | $2.3B | $671.5M | ||
| Q3 25 | — | $630.4M | ||
| Q2 25 | — | $638.8M | ||
| Q1 25 | — | $514.7M | ||
| Q4 24 | $2.1B | $538.6M | ||
| Q3 24 | — | $483.4M | ||
| Q2 24 | — | $481.8M | ||
| Q1 24 | — | $352.0M |
股东权益AMEDCI
| Q4 25 | $10.6B | $1.5B | ||
| Q3 25 | $10.5B | $1.5B | ||
| Q2 25 | $10.4B | $1.5B | ||
| Q1 25 | $10.0B | $1.5B | ||
| Q4 24 | $9.7B | $1.5B | ||
| Q3 24 | $9.6B | $1.5B | ||
| Q2 24 | $9.3B | $1.5B | ||
| Q1 24 | $9.0B | $1.4B |
总资产AMEDCI
| Q4 25 | $16.1B | $3.0B | ||
| Q3 25 | $16.2B | $3.0B | ||
| Q2 25 | $15.3B | $3.0B | ||
| Q1 25 | $14.9B | $3.0B | ||
| Q4 24 | $14.6B | $3.0B | ||
| Q3 24 | $14.8B | $2.9B | ||
| Q2 24 | $14.8B | $2.9B | ||
| Q1 24 | $14.9B | $2.8B |
负债/权益比AMEDCI
| Q4 25 | 0.21× | 0.44× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | 0.22× | 0.35× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | — | 0.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $584.3M | $125.4M |
| 自由现金流经营现金流 - 资本支出 | $527.3M | $111.2M |
| 自由现金流率自由现金流/营收 | 26.4% | 11.9% |
| 资本支出强度资本支出/营收 | 2.9% | 1.5% |
| 现金转化率经营现金流/净利润 | 1.47× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $1.7B | $403.2M |
8季度趋势，按日历期对齐
经营现金流AMEDCI
| Q4 25 | $584.3M | $125.4M | ||
| Q3 25 | $440.9M | $167.8M | ||
| Q2 25 | $359.1M | $87.7M | ||
| Q1 25 | $417.5M | $90.4M | ||
| Q4 24 | $550.0M | $72.9M | ||
| Q3 24 | $487.2M | $126.0M | ||
| Q2 24 | $381.4M | $141.5M | ||
| Q1 24 | $410.2M | $87.0M |
自由现金流AMEDCI
| Q4 25 | $527.3M | $111.2M | ||
| Q3 25 | $420.0M | $147.5M | ||
| Q2 25 | $329.8M | $73.0M | ||
| Q1 25 | $394.5M | $71.5M | ||
| Q4 24 | $498.3M | $47.9M | ||
| Q3 24 | $460.9M | $106.2M | ||
| Q2 24 | $360.0M | $120.2M | ||
| Q1 24 | $382.6M | $65.7M |
自由现金流率AMEDCI
| Q4 25 | 26.4% | 11.9% | ||
| Q3 25 | 22.2% | 15.0% | ||
| Q2 25 | 18.5% | 7.8% | ||
| Q1 25 | 22.8% | 8.2% | ||
| Q4 24 | 28.3% | 5.3% | ||
| Q3 24 | 27.0% | 11.4% | ||
| Q2 24 | 20.8% | 13.0% | ||
| Q1 24 | 22.0% | 7.5% |
资本支出强度AMEDCI
| Q4 25 | 2.9% | 1.5% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 1.6% | 1.6% | ||
| Q1 25 | 1.3% | 2.2% | ||
| Q4 24 | 2.9% | 2.8% | ||
| Q3 24 | 1.5% | 2.1% | ||
| Q2 24 | 1.2% | 2.3% | ||
| Q1 24 | 1.6% | 2.4% |
现金转化率AMEDCI
| Q4 25 | 1.47× | 1.10× | ||
| Q3 25 | 1.19× | 1.47× | ||
| Q2 25 | 1.00× | 1.52× | ||
| Q1 25 | 1.19× | 0.94× | ||
| Q4 24 | 1.42× | 0.74× | ||
| Q3 24 | 1.43× | 1.15× | ||
| Q2 24 | 1.13× | 1.25× | ||
| Q1 24 | 1.32× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
DCI
| Aftermarket Products | $447.1M | 48% |
| Industrial Filtration Solutions Products | $222.6M | 24% |
| Off Road Products | $86.5M | 9% |
| Life Sciences Segment | $80.0M | 9% |
| Other | $39.1M | 4% |
| Aerospace And Defense Products | $37.1M | 4% |
| On Road Products | $23.0M | 2% |
